Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Aoxing To Acquire TCM Pain Drug Company

publication date: Mar 12, 2008

China Aoxing Pharma Company, Inc. will pay $19.6 million to buy Shijiazhuang Lerentang Pharmaceutical Company Ltd. (LRT), a company that makes traditional Chinese medicines. Like China Aoxing, LRT concentrates on pain medications. Even though China Aoxing is perpetually short on cash, it did not designate a source for the $10.8 million cash part of the offer. More details...

Stock Symbol: (OTCBB: CAXG)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital